How to Help Your Patients Find Dovato (Dolutegravir/Lamivudine) in Stock: A Provider's Guide

As an HIV provider, you understand that antiretroviral adherence is non-negotiable. A missed week of Dovato (dolutegravir/lamivudine) is not just an inconvenience — it's a clinical event that can reset viral suppression and, in some circumstances, foster resistance. Yet specialty drug distribution in the United States means that even a patient with insurance, a valid prescription, and full motivation can be left waiting at the pharmacy counter.

This guide provides a practical, stepwise approach to minimizing Dovato access failures in your patient population — from identifying reliable pharmacy partners to navigating prior authorization and enrolling patients in manufacturer support programs.

Step 1: Verify Pharmacy Inventory Before Sending the Prescription

The most preventable access failure happens when a prescription is routed to a pharmacy that doesn't have Dovato in stock. A simple inventory check before sending the prescription can eliminate 1–3 day delays.

Recommended tool: medfinder for Providers allows your team to check real-time pharmacy inventory by medication name and ZIP code. When a Dovato prescription is being written or renewed, a brief inventory check can identify the closest pharmacy with stock — allowing you to route the prescription directly there. Assign this as a routine step for medical assistants or pharmacy liaisons whenever Dovato is prescribed.

Step 2: Build a Reliable Pharmacy Network

Rather than relying on patients to find their own pharmacy, build a curated list of 3–5 pharmacies in your service area that consistently stock Dovato. This list should include:

• At least one HIV-specialty pharmacy — these maintain proactive ARV inventory and are the most reliable source for Dovato.
• One or two independent pharmacies serving HIV patients — often more responsive and flexible than large chains.
• A mail-order specialty pharmacy option — for patients comfortable with home delivery and who prefer 90-day supply cycles.

Share this curated pharmacy list with your front desk and nursing staff so they can guide patients at the time of prescribing and refill. ViiV Connect (1-844-588-3288) also offers a pharmacy locator service that can help identify HIV-specialty pharmacies in your area.

Step 3: Submit Prior Authorization Proactively

Prior authorization (PA) is one of the most common sources of Dovato access delay. Many commercial payers and some Medicaid programs require PA for Dovato before coverage begins. PA approval timelines can range from 24 hours to 5+ business days depending on the payer.

Best practices for PA management:

• Submit PA at the time of initial prescribing, before the patient visits the pharmacy.
• Track PA renewal dates — many PA approvals are time-limited (e.g., 1 year) and expire without warning.
• Include supporting documentation: current viral load, CD4 count, treatment history, and rationale for the two-drug regimen.
• Use ViiV Connect's PA support services (1-844-588-3288) for complex cases or plan denials requiring appeal.

Step 4: Enroll Patients in ViiV Connect at Time of Prescribing

ViiV Healthcare's ViiV Connect program (1-844-588-3288) provides comprehensive patient support for Dovato, including:

• Copay savings card: Commercially insured patients may pay as little as $0/month.
• Patient Assistance Program: Provides Dovato free of charge for qualifying uninsured or underinsured patients (singles earning less than approximately $40,000/year may qualify).
• Pharmacy locator: Identifies pharmacies near the patient with Dovato in stock.
• PA support: Assists with prior authorization submissions and appeals.

Enrolling patients at the first prescription visit is the most efficient approach — it activates the safety net before a crisis arises.

Step 5: Maintain Office Samples for Emergency Bridging

Work with your ViiV Healthcare representative to maintain a small Dovato sample supply in your office. Samples can bridge the gap for patients facing pharmacy delays, PA hold-ups, or sudden insurance changes. Even a 5–7 day bridge supply can prevent a clinically meaningful interruption in treatment.

Step 6: Counsel Patients on Proactive Refill Habits

Reinforce at every visit that patients should begin the refill process 7–10 days before running out. This simple habit catches most pharmacy delays before they become adherence gaps. Key patient counseling points:

• Never wait until the last tablet to refill.
• If the pharmacy says they need to order it, ask for a timeline and follow up.
• Contact the clinic immediately if they anticipate running out — do not just stop taking the medication.

When a Temporary Regimen Switch Is Necessary

In rare cases when Dovato truly cannot be obtained within a clinically safe timeframe, a temporary switch may be appropriate. Key clinical considerations:

• Assess for HBV co-infection — any alternative must provide adequate HBV coverage if needed.
• For HBV-negative patients, Biktarvy (BIC/FTC/TAF) is the most widely available first-choice alternative.
• Plan to switch back to Dovato once it becomes available if that remains the preferred regimen.

Summary Checklist for Providers

At each Dovato prescribing or renewal visit:

• Verify pharmacy inventory using medfinder for Providers.
• Route prescription to a pharmacy confirmed to have Dovato in stock.
• Confirm PA is active and not pending renewal.
• Confirm patient is enrolled in ViiV Connect and has a copay card if commercially insured.
• Remind patient to start refill process 7–10 days before running out.

For a real-time tool to check pharmacy availability of Dovato, visit medfinder for Providers at medfinder.com/providers.